PP
BDSI

PDT Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

PDT Partners’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-29,468
Closed -$128K – 917
2020
Q2 		$128K Sell
29,468
-3,032
-9% -$13.6K 0.01% 620
2020
Q1 		$123K Buy
32,500
+8,991
+38% +$44.2K 0.01% 603
2019
Q4 		$149K Buy
+23,509
New +$138K 0.01% 671

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PDT Partners's BDSI Position: Q3 2020 in Review

PDT Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 29,468 shares — an estimated $128K sold.

PDT Partners first reported a position in BDSI in Q4 2019 and held it in 3 quarters. The position peaked at $149K in Q4 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • PDT Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • PDT Partners sold 29,468 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $128K.
  • PDT Partners first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 3 quarters.
  • PDT Partners's BioDelivery Sciences International, Inc. position peaked at $149K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on PDT Partners's 13F filing for Q3 2020, filed 16 Nov 2020.